Literature DB >> 18696036

[Antibiotic prophylaxis for patients with transurethral resection of the prostate (TUR-P)].

S Schmiedl1, P A Thürmann, S Roth.   

Abstract

BACKGROUND: For patients undergoing urologic interventions, relevant aspects of antibiotic prophylaxis such as drug of choice and duration of prophylaxis are still discussed controversially. According to the current European and German guidelines, single-shot prophylaxis is recommended only in patients with risk factors.
METHODS: Discussion of two published meta-analyses with regard to of recently published randomized controlled trials.
RESULTS: Two comprehensive meta-analyses concordantly revealed a significant reduction in bacteriuria and fever incidence without stratification according to preexisting risk factors. A single antibiotic dose ("single shot") of, for example, a cephalosporin or chinolone reduced the bacteriuria rate significantly. However, for the cephalosporines, the most frequently studied drug class, repeated dosing seems to be more effective.
CONCLUSION: Antibiotic prophylaxis reduces the rates of bacteriuria and fever in patients without existing risk factors undergoing transurethral resection of the prostate. The optimal duration of antibiotic prophylaxis and the drug of choice must be evaluated in further studies investigating clinically relevant endpoints.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18696036     DOI: 10.1007/s00120-008-1856-5

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  11 in total

1.  Incidence and risk factors of bacteriuria after transurethral resection of the prostate.

Authors:  A Colau; J C Lucet; P Rufat; H Botto; G Benoit; A Jardin
Journal:  Eur Urol       Date:  2001-03       Impact factor: 20.096

2.  [Guideline for perioperative prevention in interventions on the urinary tract and male genitalia. German Society of Urology]].

Authors: 
Journal:  Urologe A       Date:  2001-01       Impact factor: 0.639

3.  EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU).

Authors:  K G Naber; B Bergman; M C Bishop; T E Bjerklund-Johansen; H Botto; B Lobel; F Jinenez Cruz; F P Selvaggi
Journal:  Eur Urol       Date:  2001-11       Impact factor: 20.096

4.  Timing of antibiotic prophylaxis with cefotaxime for prostatic resection: better in the operative period or at urethral catheter removal?

Authors:  J M Duclos; P Larrouturou; P Sarkis
Journal:  Am J Surg       Date:  1992-10       Impact factor: 2.565

5.  Best practice policy statement on urologic surgery antimicrobial prophylaxis.

Authors:  J Stuart Wolf; Carol J Bennett; Roger R Dmochowski; Brent K Hollenbeck; Margaret S Pearle; Anthony J Schaeffer
Journal:  J Urol       Date:  2008-02-20       Impact factor: 7.450

6.  Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500 mg levofloxacin versus 1920 mg trimethoprim/sulfamethoxazole versus a control group in patients undergoing TUR of the prostate.

Authors:  F M E Wagenlehner; C Wagenlehner; S Schinzel; K G Naber
Journal:  Eur Urol       Date:  2005-01-18       Impact factor: 20.096

7.  Prophylactic antibiotic use in transurethral prostatic resection: a meta-analysis.

Authors:  Alexander Berry; Alexandra Barratt
Journal:  J Urol       Date:  2002-02       Impact factor: 7.450

Review 8.  Antibiotic prophylaxis for transurethral prostatic resection in men with preoperative urine containing less than 100,000 bacteria per ml: a systematic review.

Authors:  Wei Qiang; Wu Jianchen; Roderick MacDonald; Manoj Monga; Timothy J Wilt
Journal:  J Urol       Date:  2005-04       Impact factor: 7.450

9.  A prospective randomized and placebo-controlled study for the evaluation of antibiotic prophylaxis in transurethral resection of the prostate.

Authors:  Metin Ozturk; Orhan Koca; Cevdet Kaya; M Ihsan Karaman
Journal:  Urol Int       Date:  2007       Impact factor: 2.089

10.  A randomized and prospective study on the value of antibiotic prophylaxis administration in transurethral resection of the prostate.

Authors:  Paulo Rodrigues; Flávio Hering; Alex Meller; João Carlos Campagnari; Márcio D'Império
Journal:  Sao Paulo Med J       Date:  2004-07-01       Impact factor: 1.044

View more
  3 in total

1.  Efficacy of 1 versus 3 days of intravenous amikacin as a prophylaxis for patients undergoing transurethral resection of the prostate: A prospective randomized trial.

Authors:  Selvin Theodore Jayanth; J Chandrasingh; Rani Diana Sahni; Rajiv Paul Mukha; Santosh Kumar; Antony Devasia; Nitin Sudhakar Kekre
Journal:  Indian J Urol       Date:  2021-04-01

2.  Mulitcenter study on antibiotic prophylaxis, infectious complications and risk assessment in TUR-P.

Authors:  Laila Schneidewind; Jennifer Kranz; Daniel Schlager; Dimitri Barski; Sandra Mühlsteadt; Markus Grabbert; Fabian Queissert; Tanja Frank; Alexandre Egon Pelzer
Journal:  Cent European J Urol       Date:  2017-01-18

3.  Facklamia hominis bacteremia after transurethral resection of the prostate: a case report.

Authors:  Miriam Gahl; Thomas Stöckli; René Fahrner
Journal:  BMC Urol       Date:  2020-12-07       Impact factor: 2.264

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.